Genomenon Inc.
Ann Arbor, MI
- UEI
- Z1NLALZ88SE1
- CAGE
- 7HFW9
- Primary NAICS
- 541519 Other Computer Related Services
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3135 S State St, Ann Arbor, MI 48108, USA
- Website
- genomenon.com
- Founded
- 2014
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $300,250 |
| FY2025 | $300,250 |
| FY2024 | $300,250 |
| FY2023 | $315,100 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $300,250 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Genomenon mstermind professional licenses | CDC Pittsburgh | $1,201,000 | |
| Genomenon, INC.:1283762 [23-000319] | National Institute of Nursing Research (NIH) | $14,850 | |
| Software license | CDC Pittsburgh | $78,500 |
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Washington | R01HD115326 | $56,760 | |
| University Of Washington | R01HD115326 | $56,760 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Frameshift Labs, Inc. | Cambridge, MA | — |
| Theiagen Genomics | Littleton, CO | 541511 Custom Computer Programming Services |
| Broad Institute Of MIT And Harvard | Cambridge, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Sophia Genetics, Inc. | Boston, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Constantiam Biosciences Inc. | Katy, TX | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Genomenon Inc. is an AI-driven genomics company that provides software and solutions to transform complex genetic data into actionable insights for clinical diagnostics and drug research and development. Through federal contracts, the company has provided professional software licenses and application programming interface access to its Mastermind Genomic search engine and literature curation solution. This includes a $1.2 million contract with the CDC to enhance the National Newborn Screening Data Platform, as well as contracts with NIH and CDC to provide its genomic database and interpretation capabilities.
Past federal contracts awarded to Genomenon as a prime contractor include definitive and purchase order contracts from CDC and NIH, with no set-aside designations. These contracts aimed to leverage Genomenon's existing variant curation database to support genomic data platform development efforts. Services provided encompass software licenses, database access, and literature search and indexing capabilities.
Through a prime federal grant from the NIH National Human Genome Research Institute, Genomenon has also provided research and development services focused on automating genome sequence variant interpretation from medical literature. This involves developing a micropublication platform integrated with its Mastermind software to organize disease, gene and variant data from scientific articles. The goal is to assemble pre-curated genome data to enable immediate, accurate and collaborative variant interpretations for diagnostic and therapeutic applications. Over $4 million in total funding has been awarded to support improving diagnostic rates and accuracy in clinical and pharmaceutical applications.
Quick answers
Is Genomenon Inc. registered in SAM.gov?
Yes. Genomenon Inc.'s SAM.gov registration is active through February 26, 2027.
What is Genomenon Inc.'s CAGE code?
Genomenon Inc.'s CAGE code is 7HFW9, and its Unique Entity ID (UEI) is Z1NLALZ88SE1.
How much has Genomenon Inc. received in federal contracts?
Federal contracts obligated $300,250 to Genomenon Inc. in fiscal year 2025 and $1,215,850 in fiscal years 2023 through 2027.
What is Genomenon Inc.'s most recent federal award?
Genomenon Inc.'s most recent federal contract award is Genomenon mstermind professional licenses (75D30123C16469), from CDC Pittsburgh, on September 12, 2023.
On GovTribe
See Genomenon Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors